Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials

Authors: Martin H. Prins, Anthonie W.A. Lensing, Tim Brighton, Roger M. Lyons, Jeffrey Rehm, Mila Trajanovic, Bruce L. Davidson, Jan Beyer‐Westendorf, Ákos F. Pap, Scott D. Berkowitz, Alexander T. Cohen, Michael J. Kovacs, Philip S. Wells, Paolo Prandoni - The Lancet 2014 cited by 284